Abstract: The present invention is generally related to methods of digesting ?-amylase/trypsin inhibitors (ATI), and to the treatment and/or prophylaxis of an ?-amylase/trypsin inhibitor (ATI) mediated conditions.
Type:
Application
Filed:
May 12, 2021
Publication date:
June 8, 2023
Applicant:
GLUTAGEN PTY LTD
Inventors:
Michelle Lisa COLGRAVE, Angéla JUHÁSZ, Gregory John TANNER, Ezequiel PENA
Abstract: The present invention provides compositions for use in the prophylaxis or treatment of a condition arising from gluten intolerance, the compositions including at least partially purified caricain (or a biologically active fragment, analogue or variant thereof) alone or in combination with other suitable enzymes including bromelain, and/or an intestinal extract, as herein described. The present invention also provides methods of using such compositions for the prophylaxis or treatment of a condition arising from gluten intolerance.
Type:
Grant
Filed:
September 24, 2018
Date of Patent:
October 29, 2019
Assignee:
Glutagen Pty Ltd.
Inventors:
Teodor Stelmasiak, Hugh James Beatty Cornell
Abstract: The present invention provides compositions for use in the prophylaxis or treatment of a condition arising from gluten intolerance, the compositions including at least partially purified caricain (or a biologically active fragment, analog or variant thereof) alone or in combination with other suitable enzymes including bromelain, and/or an intestinal extract, as herein described. The present invention also provides methods of using such compositions for the prophylaxis or treatment of a condition arising from gluten intolerance.
Type:
Grant
Filed:
January 6, 2010
Date of Patent:
October 16, 2018
Assignee:
Glutagen Pty Ltd
Inventors:
Teodor Stelmasiak, Hugh James Beatty Cornell
Abstract: The present invention provides compositions for use in the prophylaxis or treatment of a condition arising from gluten intolerance, the compositions including at least partially purified caricain (or a biologically active fragment, analogue or variant thereof) alone or in combination with other suitable enzymes including bromelain, and/or an intestinal extract, as herein described. The present invention also provides methods of using such compositions for the prophylaxis or treatment of a condition arising from gluten intolerance.
Type:
Application
Filed:
January 6, 2010
Publication date:
February 9, 2012
Applicant:
Glutagen Pty Ltd.
Inventors:
Teodor Stelmasiak, Hugh James Beatty Cornell